| #29 |
Jon Shepherd |
Vifor (International) Ag |
1 |
| #29 |
William Ian Fraser David |
The Science And Technology Facilities Council |
1 |
| #29 |
Francesca Ann Day |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #29 |
Andrew Miller |
Vertex Pharmaceuticals Incorporated |
1 |
| #29 |
Phil Ligrani |
University Of Utah |
1 |
| #29 |
Malcolm Walters |
Cisco |
1 |
| #29 |
Sarah Emily Richardson |
Ucb Biopharma Srl |
1 |
| #29 |
Lauren Jayne Sudlow |
Summit Corporation Plc |
1 |
| #29 |
Juan-Miguel Jimenez |
Vertex Pharmaceuticals Incorporated |
1 |
| #29 |
Olivier De Moor |
Summit Corporation Plc |
1 |
| #29 |
Laura Claire Reed |
Ucb Biopharma Srl |
1 |
| #29 |
Gorka Etxebarria I Jardi |
Vertex Pharmaceuticals Incorporated |
1 |
| #29 |
Francoise Pierard |
Vertex Pharmaceuticals Incorporated |
1 |
| #29 |
Amanda Harding |
Green Biologics Limited |
1 |
| #29 |
Steven James Heggie |
— |
1 |
| #29 |
Naomi Went |
Chdi Foundation |
1 |
| #29 |
Oliver Philps |
Glaxo Group Limited |
1 |
| #29 |
Alan Geoffrey Roach |
Rhone-Poulenc Rorer Limited |
1 |
| #29 |
Angus Zoen Lau |
GE |
1 |
| #29 |
Won Cheal Kang |
Kraft Foods R & D |
1 |
| #29 |
Julian M. C. Golec |
Vertex Pharmaceuticals Incorporated |
1 |
| #29 |
Peter Randall |
Viavi Solutions Uk Limited |
1 |
| #29 |
Greg Kemmitt |
Dow Agrosciences |
1 |